Dent's Disease

Genetic Diseases of the Kidney

Volumn , Issue , 2009, Pages 213-226

  Scheinman, Steven J ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349349572     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-449851-8.00012-7     Document Type: Chapter

References (100)

1. Akuta N, Lloyd SE, Igarashi T, et al. Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int. 1997, 52:911-916.
2. Alonso S, Armour JA Compound haplotypes at Xp11.23 and human population growth in Eurasia. Ann. Hum. Genet. 2004, 68:428-437.
3. Anton-Gamero M, Claverie-Martin F, Garcia-Nieto V, Vela-Enriquez F, Garcia-Martinez E, Perez-Navero JL Chloride and sodium renal tubular handling in Dent's disease. Pediatr. Nephrol. 2005, 20:1198-1199.
4. Apodaca G Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton. Traffic 2001, 2:149-159.
5. Besbas N, Ozaltin F, Jeck N, Seyberth H, Ludwig M CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent's disease. Nephrol. Dial. Transplant 2005, 20:1476-1479.
6. Bolino A, Devoto M, Enia G, Zoccali CJW, Romeo G A new form of X-linked hypophosphatemic rickets with hypercalciuria (HPDR II) maps in the Xp11 region. Eur. J. Hum. Genet. 1993, 1:269-279.
7. Bosio M, Bianchi ML, Lloyd SE, Thakker RV A familial syndrome due to Arg648Stop mutation in the X-linked renal chloride channel gene. Pediatr. Nephrol. 1999, 13:278-283.
8. Brakemeier S, Si H, Gollasch M, Hoffler D, Buhl M, Kohler R, Hoyer J, Eichler I Dent's disease: identification of a novel mutation in the renal chloride channel CLCN5. Clin. Nephrol. 2004, 62:387-390.
9. Brandt S, Jentsch TJ ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett. 1995, 377:15-20.
10. Carballo-Trujillo I, Garcia-Nieto V, Moya-Angeler FJ, et al. Novel truncating mutations in the ClC-5 chloride channel gene in patients with Dent's disease. Nephrol. Dial. Transplant. 2003, 18:717-723.
11. Carr G, Simmons N, Sayer J A role for CBS domain 2 in trafficking of chloride channel CLC-5. Biochem. Biophys. Res. Commun. 2003, 310:600-605.
12. Carr G, Simmons NL, Sayer JA Disruption of clc-5 leads to a redistribution of annexin A2 and promotes calcium crystal agglomeration in collecting duct epithelial cells. Cell. Mol. Life Sci. 2006, 63:367-377.
13. Cebotaru V, Kaul S, Devuyst O, et al. High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease. Kidney Int. 2005, 68:642-652.
14. Charnas LR, Nussbaum RL The oculocerebrorenal syndrome of Lowe (Lowe syndrome). The Metabolic and Molecular Bases of Inherited Disease 2001, 6257-6266. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
15. Cheong HI, Lee JW, Zheng SH, et al. Phenotype and genotype of Dent's disease in three Korean boys. Pediatr. Nephrol. 2005, 20:455-459.
16. Choudhury R, Diao A, Zhang F, et al. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol. Biol. Cell. 2005, 16:3467-3479.
17. Christensen EI, Devuyst O, Dom G, et al. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc. Natl Acad. Sci. USA 2003.
18. Christensen EI, Willnow TE Essential role of megalin in renal proximal tubule for vitamin homeostasis. J. Am. Soc. Nephrol. 2003, 10:2224-2236.
19. Claverie-Martin F, Gonzalez-Acosta H, Flores C, Anton-Gamero M, Garcia-Nieto V De novo insertion of an Alu sequence in the coding region of the CLCN5 gene results in Dent's disease. Hum. Genet. 2003, 113:480-485.
20. Cox JP, Yamamoto K, Christie PT, et al. Renal chloride channel, CLCN5, mutations in Dent's disease. J. Bone Miner. Res. 1999, 14:1536-1542.
21. Curhan GC, Willett WC, Rimm EB, Stampfer MJ A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N. Engl. J. Med. 1993, 328:833-838.
22. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann. Intern. Med. 1997, 126:497-504.
23. Cutillas PR, Chalkley RJ, Hansen KC, et al. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 2004, 287:F353-F364.
24. Dent CE, Friedman M Hypercaliuric rickets associated with renal tubular damage. Arch. Dis. Child. 1964, 39:240-249.
25. Devuyst O, Christie PT, Courtoy PJ, Beauwens R, Thakker RV Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum. Mol. Genet. 1999, 8:247-257.
26. Dressman MA, Olivos-Glander IM, Nussbaum RL, Suchy SF Ocrl1, a PtdIns(4,5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells. J. Histochem. Cytochem. 2000, 48:179-190.
27. Dutzler R, Campbell EB, Cadene M, Chait BT, MacKinnon R X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 2002, 415:287-294.
28. Fisher SE, Black GCM, Lloyd SE, Wrong OM, Thakker RV, Craig IW Isolation and partial characterization of a human chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an hereditary nephrolithiasis). Hum. Mol. Genet. 1994, 3:2053-2059.
29. Fisher SE, Van Bakel I, Lloyd SE, Pearce SHS, Thakker RV, Craig IW Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics 1995, 29:598-606.
30. Forino M, Graziotto R, Tosetto E, Gambaro G, D'Angelo A, Anglani F Identification of a novel splice site mutation of CLCN5 gene and characterization of a new alternative 5' UTR end of ClC-5 mRNA in human renal tissue and leukocytes. J. Hum. Genet. 2004, 49:53-60.
31. Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET X-linked recessive nephrolithiasis with renal failure. N. Engl. J. Med. 1991, 325:681-686.
32. Gekle M, Mildenberger S, Freudinger R, Schwerdt G, Silbernagl S Albumin endocytosis in OK cells: dependence on actin and microtubules and regulation by protein kinases. Am. J. Physiol. 1997, 272:F668-F677.
33. Gekle M, Volker K, Mildenberger S, Freudinger R, Shull GE, Wiemann M NHE3 Na+/H+ exchanger supports proximal tubular protein reabsorption in vivo. Am. J. Physiol. Renal Physiol. 2004, 287:F469-F473.
34. Gunther W, Luchow A, Cluzeaud F, Vandewalle A, Jentsch TJ ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc. Natl Acad. Sci. USA 1998, 95:8075-8080.
35. Gunther W, Piwon N, Jentsch TJ The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease. Pflugers Arch. 2003, 445:456-462.
36. Hara-Chikuma M, Wang Y, Guggino SE, Guggino WB, Verkman AS Impaired acidification in early endosomes of ClC-5 deficient proximal tubule. Biochem. Biophys. Res. Commun. 2005, 329:941-946.
37. 2+-sensing receptor in divalent mineral ion homeostasis. J. Exp. Biol. 1997, 200:295-302.
38. Hoopes RR, Hueber PA, Reid RJ, et al. CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis. Kidney Int. 1998, 54:698-705.
39. Hoopes RR, Raja KM, Koich A, et al. Evidence for genetic heterogeneity in Dent's disease. Kidney Int. 2004, 65:1615-1620.
40. Hoopes RR, Shrimpton AE, Knohl SJ, et al. Dent disease with mutations in OCRL1. Am. J. Hum. Genet. 2005, 76:260-267.
41. Hryciw DH, Wang Y, Devuyst O, Pollock CA, Poronnik P, Guggino WB Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines. J. Biol. Chem. 2003, 278:40169-40176.
42. Japan disease. Kidney Int. 1998, 54:1850-1856.
43. Igarashi T, Hayakawa H, Shiraga H, et al. Hypercalciuria and nephrocalcinosis in patients with idiopathic low-molecular-weight proteinuria in Japan: is the disease identical to Dent's disease in United Kingdom?. Nephron 1995, 69:242-247.
44. Igarashi T, Inatomi J, Ohara T, Kuwahara T, Shimadzu M, Thakker RV Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease. Kidney Int. 2000, 58:520-527.
45. Janne PA, Suchy SF, Bernard D, et al. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J. Clin. Invest. 1998, 101:2042-2053.
46. Jentsch TJ Chloride transport in the kidney: lessons from human disease and knockout mice. J. Am. Soc. Nephrol. 2005, 16:1549-1561.
47. Jentsch TJ, Maritzen T, Zdebik AA Chloride channel diseases resulting from impaired transepithelial transport or vesicular function. J. Clin. Invest. 2005, 115:2039-2046.
48. Jentsch TJ, Poet M, Fuhrmann JC, Zdebik AA Physiological functions of CLC Cl2 channels gleaned from human genetic disease and mouse models. Annu. of Rev. Physiol. 2005, 67:779-807.
49. Jouret F, Igarashi T, Gofflot F, et al. Comparative ontogeny, processing, and segmental distribution of the renal chloride channel, ClC-5. Kidney Int. 2004, 65:198-208.
50. Kelleher CL, Buckalew VM, Frederickson ED, et al. CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets. Kidney Int. 1998, 53:31-37.
51. Lemann J., Pleuss J.A., Worcester E.M., Hornick L., Schrab D., Hoffmann R.G. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int. 1996, 49:200-208. [published erratum appears in Kidney Int. 1996; 50(1): 341].
52. Lloyd SE, Gunther W, Pearce SHS, et al. Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum. Mol. Genet. 1997, 6:1233-1239.
53. Lloyd SE, Pearce SH, Gunther W, et al. Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5). J. Clin. Invest. 1997, 99:967-974.
54. Lloyd SE, Pearce SHS, Fisher SE, et al. A common molecular basis for three inherited kidney stone diseases. Nature 1996, 379:445-449.
55. Ludwig M, Doroszewicz J, Seyberth HW, et al. Functional evaluation of Dent's disease-causing mutations: implications for ClC-5 channel trafficking and internalization. Hum. Genet. 2005, 117:228-237.
56. Luyckx VA, Goda FO, Mount DB, et al. Intrarenal and subcellular localization of rat CLC5. Am. J. Physiol. (Renal Fluid Electrol. Physiol.) 1998, 275:761-769.
57. Luyckx VA, Leclercq B, Dowland LK, Yu ASL Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression. Proc. Natl Acad. Sci. USA 1999, 21:12174-12179.
58. Magen D, Adler L, Mandel H, Efrati E, Zelikovic I Autosomal recessive renal proximal tubulopathy and hypercalciuria: a new syndrome. Am. J. Kidney Dis. 2004, 43:600-606.
59. Matsuyama T, Awazu M, Oikawa T, Inatomi J, Sekine T, Igarashi T Molecular and clinical studies of Dent's disease in Japan: biochemical examination and renal ultrasonography do not predict carrier state. Clin. Nephrol. 2004, 61:231-237.
60. Morimoto T, Uchida S, Sakamoto H, et al. Mutations in CLCN5 chloride channel in Japanese patients with low molecular weight proteinuria. J. Am. Soc. Nephrol. 1998, 9:811-818.
61. +-ATPase without ultrastructural changes in kidneys of Dent's disease patients. Kidney Int. 2003, 63:1285-1295.
62. Murakami T, Kawakami H The clinical significance of asymptomatic low molecular weight proteinuria detected on routine screening of children in Japan: a survey of 53 patients. Clin. Nephrol. 1990, 33:12-19.
63. Mussap M, Fanos V, Piccoli A, Zaninotto M, Padovani EM, Plebani M Low molecular mass proteins and urinary enzymes in amniotic fluid of healthy pregnant women at progressive stages of gestation. Clin. Biochem. 1996, 29:51-56.
64. Nakazato H, Hattori S, Furuse A, et al. Mutations in the CLCN5 gene in Japanese patients with familial idiopathic low-molecular-weight proteinuria. Kidney Int. 1997, 52:895-900.
65. Nakazato H, Yoshimuta J, Karashima S, et al. Chloride channel CLCN5 mutations in Japanese children with familial idiopathic low molecular weight proteinuria. Kidney Int. 1999, 55:63-70.
66. Neild GH, Thakker RV, Unwin RJ, Wrong OM Dent's disease. Nephrol. Dial. Transplant. 2005, 20:2284-2285.
67. Norden AG, Lapsley M, Igarashi T, et al. Urinary megalin deficiency implicates abnormal tubular endocytic function in fanconi syndrome. J. Am. Soc. Nephrol. 2002, 13:125-133.
68. Norden AG, Lapsley M, Lee PJ, et al. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int. 2001, 60:1885-1892.
69. Obermuller N, Gretz N, Kriz W, Reilly RF, Witzgall R The swelling-activated chloride channel ClC-2, the chloride channel ClC-3, and ClC-5, a chloride channel mutated in kidney stone disease, are expressed in distinct subpopulations of renal epithelial cells. J. Clin. Invest. 1998, 101:635-642.
70. Oudet C, Martin-Coignard D, Pannetier S, Praud E, Champion G, Hanauer A A second family with XLRH displays the mutation S244L in the CLCN5 gene. Hum. Genet. 1997, 99:781-784.
71. Picollo A, Pusch M Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 2005, 436:420-423.
72. ?-channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 2000, 408:369-373.
73. Pook MA, Wrong O, Wooding C, Norden AGW, Feest TG, Thakker RV Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum. Mol. Genet. 1993, 2:2129-2134.
74. Raja KM, Schurman S, D'Mello RG, et al. Responsiveness of hypercalciuria to thiazide in Dent's disease. J. Am. Soc. Nephrol. 2002, 13:2938-2944.
75. Rebelo MA, Tostes V, Araujo NC, et al. Screening for CLCN5 mutation in renal calcium stone formers patients. An. Acad. Bras. Cienc. 2005, 77:95-101.
76. Reinhart SC, Norden AGW, Lapsley M, et al. Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J. Am. Soc. Nephrol. 1995, 5:1451-1461.
77. Roschinger W, Muntau AC, Rudolph G, Roscher AA, Kammerer S Carrier assessment in families with Lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination. Mol. Genet. Metab. 2000, 69:213-222.
78. Santo Y, Hirai H, Shima M, et al. Examination of megalin in renal tubular epithelium from patients with Dent disease. Pediatr. Nephrol. 2004, 19:612-615.
79. Sayer JA, Carr G, Pearce SH, Goodship TH, Simmons NL Disordered calcium crystal handling in antisense CLC-5-treated collecting duct cells. Biochem. Biophys. Res. Commun. 2003, 300:305-310.
80. Sayer JA, Carr G, Simmons NL Calcium phosphate and calcium oxalate crystal handling is dependent upon CLC-5 expression in mouse collecting duct cells. Biochim. Biophys. Acta 2004, 1689:83-90.
81. Scheel O, Zdebik AA, Lourdel S, Jentsch TJ Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature 2005, 436:424-427.
82. Scheinman SJ X-linked hypercalciuric nephrolithiasis: Clinical syndromes and chloride channel mutations. Kidney Int. 1998, 53:3-17.
83. Scheinman SJ Nephrolithiasis. Sem. Nephrol. 1999, 19:381-388.
84. Scheinman SJ, Cox JPD, Lloyd SE, et al. Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria. Kidney Int. 2000, 57:232-239.
85. Scheinman SJ, Pook MA, Wooding C, Pang JT, Frymoyer PA, Thakker RV Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies. J. Clin. Invest. 1993, 91:2351-2357.
86. Scheinman SJ, Thakker RV X-linked nephrolithiasis/Dent's disease and mutations in the ClC-5 chloride channel. Genetic Aspects of Osteoporosis and Metabolic Bone Disease 2000, 133-152. Humana Press, Totowa, N.J. M.J. Econs (Ed.).
87. Schurman SJ, Norden AGW, Scheinman SJ X-linked recessive nephrolithiasis: Presentation and diagnosis in children. J. Pediatr. 1998, 132:859-862.
88. Schwake M, Friedrich T, Jentsch TJ An internalization signal in ClC-5, an endosomal Cl-channel mutated in dent's disease. J. Biol. Chem. 2001, 276:12049-12054.
89. Silva IV, Cebotaru V, Wang H, et al. The CLC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover. J. Bone Miner. Res. 2003, 18:615-623.
90. Steinmeyer K, Schwappach B, Bens M, Vandewalle A, Jentsch TJ Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease. J. Biol. Chem. 1995, 270:31172-31177.
91. Suchy SF, Nussbaum RL The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization. Am. J. Hum. Genet. 2002, 71:1420-1427.
92. Takemura T, Hino S, Ikeda M, et al. Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease). Am. J. Kidney Dis. 2001, 37:138-143.
93. Tosetto E, Graziotto R, Artifoni L, et al. Dent's disease and prevalence of renal stones in dialysis patients in Northeastern Italy. J. Hum. Genet. 2006, 51:25-30.
94. Vandewalle A, Cluzeaud F, Peng KC, et al. Tissue distribution and subcellular localization of the ClC-5 chloride channel in rat intestinal cells. Am. J. Physiol. Cell. Physiol. 2001, 280:C373-C381.
95. Wang SS, Devuyst O, Courtoy PJ, et al. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum. Mol. Genet. 2000, 9:2937-2945.
96. Wang Y, Cai H, Cebotaru L, et al. ClC-5: role in endocytosis in the proximal tubule. Am. J. Physiol. Renal Physiol. 2005, 289:F850-F862.
97. Wrong O, Norden AGW, Feest TG Dent's disease: a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure, and a marked male predominance. Q. J. Med. 1994, 87:473-493.
98. Wu F, Roche P, Christie PT, et al. Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. Kidney Int. 2003, 63:1426-1432.
99. Yamamoto K, Cox JP, Friedrich T, et al. Characterization of renal chloride channel (CLCN5) mutations in Dent's disease. J. Am. Soc. Nephrol. 2000, 11:1460-1468.
100. Yanagida H, Ikeoka M, Kuwajima H, et al. A boy with Japanese Dent's disease exhibiting abnormal calcium metabolism and osseous disorder of the spine: defective megalin expression at the brush border of renal proximal tubules. Clin. Nephrol. 2004, 62:306-312.